Doxazosin: Effective Management of Hypertension and BPH Symptoms
| Product dosage: 1 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.33 | $39.56 (0%) | 🛒 Add to cart |
| 180 | $0.30 | $59.34 $53.32 (10%) | 🛒 Add to cart |
| 270 | $0.27 | $89.01 $73.96 (17%) | 🛒 Add to cart |
| 360 | $0.26
Best per pill | $118.68 $94.60 (20%) | 🛒 Add to cart |
| Product dosage: 2 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.70 | $42.14 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $63.21 $53.32 (16%) | 🛒 Add to cart |
| 120 | $0.54 | $84.28 $64.50 (23%) | 🛒 Add to cart |
| 180 | $0.49 | $126.42 $87.72 (31%) | 🛒 Add to cart |
| 270 | $0.45 | $189.63 $121.26 (36%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $252.84 $155.66 (38%) | 🛒 Add to cart |
| Product dosage: 4 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.20 | $36.12 (0%) | 🛒 Add to cart |
| 60 | $0.97 | $72.24 $58.48 (19%) | 🛒 Add to cart |
| 90 | $0.91 | $108.36 $81.70 (25%) | 🛒 Add to cart |
| 120 | $0.87 | $144.48 $104.06 (28%) | 🛒 Add to cart |
| 180 | $0.83 | $216.72 $149.64 (31%) | 🛒 Add to cart |
| 270 | $0.81 | $325.08 $217.58 (33%) | 🛒 Add to cart |
| 360 | $0.79
Best per pill | $433.44 $285.52 (34%) | 🛒 Add to cart |
Synonyms | |||
Doxazosin is an alpha-1 adrenergic blocker medication primarily prescribed for the management of hypertension (high blood pressure) and the symptomatic treatment of benign prostatic hyperplasia (BPH). As a selective antagonist of postsynaptic alpha-1 adrenergic receptors, it exerts its therapeutic effects by causing peripheral vasodilation and relaxation of smooth muscle in the prostate and bladder neck. This dual mechanism of action makes it a versatile agent in cardiovascular and urological therapeutics, offering a well-established profile for improving patient quality of life through controlled blood pressure reduction and relief of urinary obstruction symptoms.
Features
- Pharmacological Class: Quinazoline-derived alpha-1 adrenergic receptor antagonist.
- Available Formulations: Immediate-release (Doxazosin) and extended-release (Doxazosin XL) tablets.
- Standard Strengths: 1 mg, 2 mg, 4 mg, and 8 mg tablets.
- Mechanism of Action: Selective blockade of alpha-1 adrenoceptors in vascular smooth muscle and the prostate.
- Bioavailability: Approximately 65% following oral administration.
- Half-Life: 19–22 hours for immediate-release; permits once-daily dosing.
- Metabolism: Hepatic, primarily via CYP3A4 isoenzyme.
- Excretion: Principally fecal (63%) with minor renal elimination (9%).
Benefits
- Effectively lowers blood pressure by reducing peripheral vascular resistance.
- Improves urinary flow rates and reduces symptoms of BPH, such as hesitancy, nocturia, and incomplete bladder emptying.
- Does not adversely affect blood lipid profiles or insulin sensitivity.
- May be used concomitantly with other antihypertensive agents for additive effects.
- The extended-release formulation minimizes peak-trough fluctuations, enhancing tolerability.
- Rapid onset of action for symptomatic relief in BPH, often within 1–2 weeks.
Common use
Doxazosin is indicated for the treatment of mild to moderate hypertension, either as monotherapy or in combination with other antihypertensive drugs such as diuretics, beta-blockers, or ACE inhibitors. In urology, it is used for the symptomatic treatment of benign prostatic hyperplasia to improve urine flow and reduce obstructive and irritative symptoms. Off-label uses may include the management of ureteral stones and adjunct treatment in pheochromocytoma, though these are not primary indications.
Dosage and direction
For hypertension, the initial dose is 1 mg once daily, which may be increased to 2 mg, and thereafter up to 4 mg, 8 mg, or 16 mg daily based on blood pressure response. Dosage adjustments should generally occur at 1–2 week intervals. For BPH, the starting dose is also 1 mg daily, titrated upwards to 2–8 mg depending on symptomatic response and tolerability. The extended-release formulation (Doxazosin XL) should be taken with breakfast and must be swallowed whole; it should not be crushed or chewed. Administration at bedtime is recommended during initial titration to minimize the risk of orthostatic hypotension.
Precautions
Patients should be advised about the potential for syncope, especially with the first dose or after dosage increases. Caution is required in those with hepatic impairment due to extensive metabolism. Regular monitoring of blood pressure and prostate-specific antigen (PSA) levels is advised. Use with caution in patients with a history of gastrointestinal obstruction, as the tablet shell of XL formulations may remain intact and be visible in stool. Eye surgery patients should inform their ophthalmologist of doxazosin use due to the risk of intraoperative floppy iris syndrome (IFIS).
Contraindications
Doxazosin is contraindicated in patients with a known hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any component of the formulation. It is also contraindicated in patients with a history of orthostatic hypotension and should not be used in combination with other alpha-blockers. Use is contraindicated in patients with severe hepatic impairment.
Possible side effect
Common adverse reactions include dizziness (15–19%), fatigue (8–12%), hypotension (4–7%), edema (4–6%), and somnolence (5–6%). Less frequently, patients may experience headache, nausea, rhinitis, or postural dizziness. Serious side effects, though rare, include syncope (particularly first-dose effect), priapism, palpitations, and severe orthostatic hypotension. Patients should report any symptoms of angina or significant dizziness to their healthcare provider.
Drug interaction
Doxazosin may potentiate the hypotensive effects of other antihypertensive agents, diuretics, and phosphodiesterase-5 inhibitors (e.g., sildenafil). Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase doxazosin plasma concentrations. NSAIDs and sympathomimetics may reduce its antihypertensive efficacy. Use caution with other medications that cause hypotension or dizziness.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time of the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose is not recommended.
Overdose
Symptoms of overdose may include profound hypotension, circulatory collapse, and shock. Management involves cardiovascular support, including keeping the patient in a supine position and administering IV fluids. Vasopressors may be used if necessary; dopamine or norepinephrine are preferred. Gastric lavage may be considered if ingestion was recent.
Storage
Store at room temperature (20–25°C or 68–77°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication or treatment plan. Individual patient needs and responses may vary.
Reviews
Doxazosin has been extensively studied in clinical trials and is generally regarded as effective and well-tolerated for its indicated uses. Many patients report significant improvement in urinary symptoms and blood pressure control. Some note dizziness upon initiation, which often subsides with continued use. Medical professionals appreciate its dual indications and flexibility in dosing, though emphasize the importance of careful titration to minimize adverse effects.